Company Filing History:
Years Active: 2015
Title: Innovations of Günther Ott in RNA Delivery Systems.
Introduction
Günther Ott is a notable inventor based in Bayreuth, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of RNA interference (RNAi) delivery systems. His work focuses on developing innovative methods for targeted delivery of therapeutic agents.
Latest Patents
Günther Ott holds a patent for a peptide-based in vivo siRNA delivery system. This invention is directed towards compositions that enable the targeted delivery of RNAi polynucleotides to hepatocytes in vivo. The system utilizes co-targeted melittin delivery peptides, which facilitate the movement of RNAi polynucleotides from outside the cell to inside the cell. The reversible modification of these delivery peptides provides physiological responsiveness, enhancing the effectiveness of the treatment.
Career Highlights
Günther Ott is associated with Arrowhead Madison, Inc., where he continues to advance his research in RNA delivery systems. His work has the potential to revolutionize therapeutic approaches for various diseases by improving the efficiency of RNAi technologies.
Collaborations
He collaborates with esteemed colleagues, including David B Rozema and David L Lewis, who contribute to the development and refinement of his innovative delivery systems.
Conclusion
Günther Ott's contributions to the field of RNA delivery systems exemplify the importance of innovation in biotechnology. His patented technologies hold promise for enhancing therapeutic interventions in medicine.